---
input_text: '[Orthotopic liver transplantation at the Island Hospital. Initial experiences
  1985-1990]. Between 1985 and 1990 22 orthotopic liver transplantations (OLT) were
  realized in 19 patients. Active infection and diffuse splanchnic venous thrombosis
  were the only contra-indications to the intervention. Sixteen patients were transplanted
  electively; three had to be retransplanted urgently. Three patients had an urgent
  primary transplant. The incidence of surgical complications related to liver implantation
  was fair. One patient (5%) developed a late portal vein thrombosis; another patient
  (5%) had to be retransplanted because of hepatic artery thrombosis. All patients
  presented one or more major postoperative complications. All, but one, patients
  had a rejection of the allograft; five of them needed treatment with mono- or polyclonal
  antilymphocytic sera to reverse the rejection. One patient was retransplanted because
  of a hyperacute rejection. The six-month survival in this series is 68.5% (13 of
  18 patients); one patient died 7 months post-OLT due to a neurological complication
  of her Wilson disease. Quality of life (from 6 to 64 months post-OLT) is excellent
  in the 12 long-term survivors. This small experience of the Bernese transplantation
  program shows that liver transplantation is a safe surgical procedure allowing excellent
  quality of life in a majority of patients.'
raw_completion_output: |-
  primary_disease: Orthotopic liver transplantation (OLT)
  medical_actions: Orthotopic liver transplantation; Re-transplantation; Treatment with mono- or polyclonal antilymphocytic sera
  symptoms: Active infection; Diffuse splanchnic venous thrombosis; Late portal vein thrombosis; Hepatic artery thrombosis; Rejection of the allograft; Hyperacute rejection; Major postoperative complications
  chemicals: mono- or polyclonal antilymphocytic sera
  action_annotation_relationships: Orthotopic liver transplantation TREATS major postoperative complications IN Orthotopic liver transplantation (OLT); Re-transplantation TREATS late portal vein thrombosis IN Orthotopic liver transplantation (OLT); Re-transplantation (because of hepatic artery thrombosis) TREATS hepatic artery thrombosis IN Orthotopic liver transplantation (OLT); Treatment with mono- or polyclonal antilymphocytic sera (with mono- or polyclonal antilymphocytic sera) TREATS rejection of the allograft IN Orthotopic liver transplantation (OLT); Re-transplantation (because of a hyperacute rejection) TREATS hyperacute rejection IN Orthotopic liver transplantation (OLT)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Re-transplantation (because of a hyperacute rejection) TREATS hyperacute rejection IN Orthotopic liver transplantation (OLT)

  ===

extracted_object:
  primary_disease: Orthotopic liver transplantation (OLT)
  medical_actions:
    - Orthotopic liver transplantation
    - Re-transplantation
    - Treatment with mono- or polyclonal antilymphocytic sera
  symptoms:
    - Active infection
    - Diffuse splanchnic venous thrombosis
    - Late portal vein thrombosis
    - Hepatic artery thrombosis
    - Rejection of the allograft
    - Hyperacute rejection
    - Major postoperative complications
  chemicals:
    - mono- or polyclonal antilymphocytic sera
  action_annotation_relationships:
    - subject: <Orthotopic liver transplantation>
      predicate: <TREATS>
      object: <major postoperative complications>
      qualifier: <Orthotopic liver transplantation (OLT)>
      subject_qualifier: <Not applicable>
      object_qualifier: <Not applicable>
      subject_extension: <Not applicable>
      object_extension: <Not applicable>
    - subject: <Re-transplantation>
      predicate: <TREATS>
      object: <late portal vein thrombosis>
      qualifier: <Orthotopic liver transplantation (OLT)>
      subject_qualifier: <None>
      object_qualifier: <None>
      subject_extension: <None>
      object_extension: <None>
    - subject: Re-transplantation
      predicate: TREATS
      object: hepatic artery thrombosis
      qualifier: Orthotopic liver transplantation (OLT)
      subject_qualifier: because of hepatic artery thrombosis
    - subject: Treatment
      predicate: TREATS
      object: rejection of the allograft
      qualifier: Orthotopic liver transplantation (OLT)
      subject_qualifier: with mono- or polyclonal antilymphocytic sera
      subject_extension: mono- or polyclonal antilymphocytic sera
    - subject: Re-transplantation
      predicate: TREATS
      object: hyperacute rejection
      qualifier: Orthotopic liver transplantation (OLT)
      subject_qualifier: because of a hyperacute rejection
named_entities:
  - id: MONDO:0010200
    label: Wilson disease
  - id: MAXO:0001175
    label: liver transplantation
  - id: MAXO:0000004
    label: surgery (laparotomy, rectal mobilization, rectopexy, the partial sigmoid
      colon resection with the primary anastomosis)
  - id: HP:0002910
    label: abnormal liver functions
  - id: HP:0001394
    label: cirrhosis
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50868
    label: penicillamine
  - id: CHEBI:51232
    label: Hoechst 33342
  - id: HP:0006554
    label: acute liver failure
  - id: MAXO:0000068
    label: transplantation
  - id: MAXO:0009095
    label: Zinc therapy
  - id: HP:0002344
    label: Neurologic deterioration
  - id: MAXO:0001298
    label: therapy
  - id: HP:0001392
    label: liver disease
  - id: HP:0006579
    label: neonatal jaundice
  - id: HP:0002612
    label: congenital hepatic fibrosis
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0030151
    label: cholangitis
  - id: MONDO:0013282
    label: alpha-1-antitrypsin deficiency
  - id: MONDO:0009061
    label: cystic fibrosis
  - id: MONDO:0009044
    label: Crigler-Najjar syndrome
  - id: MAXO:0000376
    label: liver biopsy
  - id: MAXO:0000127
    label: genetic testing
  - id: HP:0001903
    label: anemia
  - id: HP:0001410
    label: liver dysfunction
  - id: CHEBI:39501
    label: trientine
  - id: CHEBI:28694
    label: copper
  - id: HP:0001399
    label: hepatic failure
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0100193
    label: end-stage liver disease
  - id: HP:0100626
    label: end-stage liver disease
  - id: HP:0100660
    label: dyskinesia
  - id: HP:0004787
    label: fulminant hepatitis
  - id: HP:0031811
    label: bilirubinuria
  - id: HP:0001397
    label: hepatic steatosis
  - id: CHEBI:16359
    label: cholic acid
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: HP:0002480
    label: Hepatic encephalopathy
  - id: CHEBI:27385
    label: CCL4
  - id: MAXO:0001017
    label: Vaccination
  - id: HP:0001541
    label: Ascites
  - id: HP:0012398
    label: Peripheral edema
  - id: HP:0001337
    label: tremor
  - id: HP:0001260
    label: dysarthria
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0200123
    label: chronic hepatitis
  - id: CHEBI:38161
    label: chelators
  - id: MAXO:0000603
    label: peritoneal dialysis
  - id: CHEBI:7959
    label: D-penicillamine
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: HP:0002172
    label: imbalance
  - id: HP:0000093
    label: proteinuria
  - id: HP:0032199
    label: abnormal prothrombin time
  - id: MAXO:0000167
    label: Antiepileptic therapy
  - id: CHEBI:61049
    label: Tacrolimus
  - id: CHEBI:9168
    label: Rapamycin
  - id: CHEBI:55379
    label: Cyclosporine (CsA)
  - id: CHEBI:35623
    label: antiepileptic
  - id: CHEBI:4031
    label: Cyclosporine
  - id: HP:0000083
    label: renal failure
  - id: CHEBI:26708
    label: NA
  - id: CHEBI:35176
    label: zinc sulphate
  - id: HP:0001251
    label: ataxia
  - id: CHEBI:166831
    label: copper chelators
  - id: HP:0006577
    label: macronodular cirrhosis
  - id: CHEBI:8830
    label: rhodanine
  - id: CHEBI:18248
    label: iron
  - id: HP:0002015
    label: dysphagia
  - id: MONDO:0021200
    label: Rare diseases
  - id: MAXO:0000011
    label: Physiotherapy
  - id: MONDO:0001516
    label: spinal muscular atrophy
  - id: HP:0100806
    label: Sepsis
  - id: CHEBI:2948
    label: Azathioprine
  - id: CHEBI:8378
    label: Prednisolone
  - id: HP:0031690
    label: opportunistic infections
  - id: HP:0001513
    label: Obesity
  - id: HP:0000819
    label: Diabetes
  - id: HP:0002829
    label: Arthralgia
  - id: HP:0003281
    label: Elevated serum ferritin
  - id: HP:0012463
    label: Elevated transferrin saturation
  - id: CHEBI:9907
    label: Ursodeoxycholic acid
  - id: MONDO:0007027
    label: Non-alcoholic steatohepatitis (NASH)
  - id: MONDO:0006507
    label: Hereditary hemochromatosis (HH)
  - id: HP:0003256
    label: Coagulopathy
  - id: HP:0001298
    label: Encephalopathy
  - id: HP:0000952
    label: Jaundice
  - id: HP:0001289
    label: Confusion
  - id: MONDO:0003441
    label: dystonia
  - id: MAXO:0009015
    label: botulinum toxin injection
  - id: MAXO:0000943
    label: deep brain stimulation
  - id: CHEBI:9720
    label: trihexyphenidyl
  - id: HP:0001332
    label: dystonia
  - id: HP:0004305
    label: involuntary movements
  - id: CHEBI:46195
    label: acetaminophen
  - id: HP:0100520
    label: oliguria
  - id: CHEBI:16737
    label: creatinine
  - id: HP:0003259
    label: elevated creatinine
  - id: HP:0100543
    label: Cognitive impairment
  - id: CHEBI:33234
    label: vitamin E
  - id: MAXO:0000070
    label: Hepatic transplantation
